FindTrial
Sign In

Human Umbilical Cord Mesenchymal Stem Cell Treatment Alleviates Experimental Dry Eye Syndrome in a Rabbit Model

Human Umbilical Cord Mesenchymal Stem Cell Treatment Alleviates Experimental Dry Eye Syndrome in a Rabbit Model

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BOC-17014128
Enrollment
Unknown
Registered
2017-12-24
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune dacryoadenitis

Interventions

Case series:human umbilical cord mesenchymal stem cells therapy

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: healthy pregnancy following caesarean section at term (37-40weeks gestation)

Exclusion criteria

Exclusion criteria: pregnancy with systemic disease; pregnancy by normal spontaneous vaginal delivery; healthy pregnancy following caesarean section at term (<37 weeks gestation)

Design outcomes

Primary

MeasureTime frame
inflammatory factors and Tregs in lacrimal glands and spleens;—

Countries

China

Contacts

Public ContactRuihua Wei

Tianjin Medical University Eye Hospital

weirhua2009@126.com+86 22-86428862

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026